Your browser doesn't support javascript.
Non-life-threatening adverse effects with COVID-19 mRNA-1273 vaccine: A randomized, cross-sectional study on healthcare workers with detailed self-reported symptoms.
Kadali, Renuka Ananth Kalyan; Janagama, Ravali; Peruru, Sharanya; Gajula, Viswanath; Madathala, Rajasekhar R; Chennaiahgari, Nikhita; Malayala, Srikrishna V.
  • Kadali RAK; Department of Internal Medicine, Harnett Health System, Affiliated with Cape Fear Valley Health System, Lillington, North Carolina, USA.
  • Janagama R; Department of Internal Medicine, Campbell University Jerry M. Wallace School of Osteopathic Medicine, Lillington, North Carolina, USA.
  • Peruru S; Kidzcare Pediatrics, Sanford, North Carolina, USA.
  • Gajula V; Department of Statistics, North Carolina State University, Raleigh, North Carolina, USA.
  • Madathala RR; Department of Pediatrics, Division of Pediatric Critical Care Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA.
  • Chennaiahgari N; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Malayala SV; Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
J Med Virol ; 93(7): 4420-4429, 2021 Jul.
Article in English | MEDLINE | ID: covidwho-1209630
ABSTRACT
There are concerns regarding the side effects of the new coronavirus disease 2019 (COVID-19) mRNA-1273 vaccine among healthcare workers (HCWs) in the United States. The objective of the study was to investigate the side effects of the mRNA-1273 vaccine with detailed review of organ systems. A randomized, cross-sectional study using an independent online survey questionnaire was conducted to collect responses from HCWs. Of all participants, 87.8% (1116/1271) provided complete responses. Of them, 38.7% (432/1116) received the mRNA-1273 vaccine, among which, 89.35% were females; 425 of these 432 mRNA-1273 vaccine recipients (98.34%) reported at least one or more symptoms. The results were classified based on the frequency of symptoms reported postvaccination. Of these, 254/432 (58.8%) were able to continue their daily routine activities. 108/432 (25%) temporarily had trouble to perform daily activities, 120/432 (27.78%) required transient time off from work, 17/432 (3.94%) required help from an outpatient provider, 1/432 (0.23%) required help from emergency department, and none of them were hospitalized. Despite the wide array of self-reported symptoms, 97.02% of the HCWs did not intend to skip the second dose of vaccine. Among all the symptoms reported, localized pain, generalized weakness, headache, myalgia, chills, fever, nausea, joint pains, sweating, localized swelling at the injection site, dizziness, itching, rash, decreased appetite, muscle spasm, decreased sleep quality, and brain fogging were the most commonly reported symptoms (in descending order of occurrence). Most of the symptoms reported were nonlife threatening. Despite the wide array of self-reported symptoms, there appears to be a higher acceptance for this vaccine.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Health Personnel / Injection Site Reaction / COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Vaccines Limits: Adult / Aged / Female / Humans / Male / Middle aged / Young adult Language: English Journal: J Med Virol Year: 2021 Document Type: Article Affiliation country: Jmv.26996

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Health Personnel / Injection Site Reaction / COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Vaccines Limits: Adult / Aged / Female / Humans / Male / Middle aged / Young adult Language: English Journal: J Med Virol Year: 2021 Document Type: Article Affiliation country: Jmv.26996